Healthcare & Life Sciences

Latham offers life sciences and healthcare industry leaders deep sector knowledge, legal expertise, and commercial and government insight to meet client needs.

Why Latham

Melding Deep Industry Experience with Commercial Insight

Companies operating in the healthcare and life sciences sectors face an increasingly complex transactional, political, and competitive landscape. Latham’s superior grasp of the regulatory regimes and market issues means that clients can adroitly and expeditiously address litigation, mergers and acquisitions, capital raising, regulatory counseling, business restructuring and reorganization, contract negotiations, fraud and abuse compliance, white collar and government investigations, operational matters, and more.


For more information on Latham’s Healthcare experience and expertise visit the Healthcare Services & Providers Industry Group page

Life Sciences

For more information on Latham’s Life Sciences experience and expertise visit the Life Sciences Industry Group page

Awards & Rankings

  • Latham Named Washington, D.C. 2019 Law Firm of the Year for Environment - June 24, 2019
  • Healthcare & Life Sciences Partner Recognized as Business of Pride Honoree - June 16, 2019
  • Healthcare & Life Sciences Vice Chair Named Technology Law Trailblazer - June 04, 2019
  • Latham Named D.C. General Litigation Department of the Year Finalist - June 02, 2019
  • Litigation & Trial Partner Named Healthcare Trailblazer - May 13, 2019

Latham is known for offering "expert representation across the full scope of matters affecting life sciences and healthcare clients, including providers." They have a "strong bench of former government attorneys who field expertise across numerous US departments and offices" and a "dominant presence in qui tam suits and criminal proceedings, as well as frequent involvement in complex transactions, including high-value M&A.”

– Chambers USA 2018


Securities Enforcement Forum 2019 Webcast: Recent Developments in Health Care Enforcement

Media Coverage

Puma Biotech Says Liability Still Unsettled In Stock-Drop RowBusiness of Pride 2019 Honoree, Stuart KurlanderTechnology Law Trailblazer: Judith Hasko


Trends in Healthcare Enforcement FDA Regulatory Considerations for Tobacco and Cannabis-Derived SubstancesSecurities Litigation Team Secures Complete Dismissal for Impax Pharmaceuticals

Thought Leadership

Time to Prepare for New EU Medical Device RegimeMHRA Releases No-Deal Brexit Guidance for Life Sciences CompaniesDrug Pricing and Payment Policy: HHS Rebate Reform Proposal